Search by Drug Name or NDC

    NDC 60687-0385-25 Colesevelam Hydrochloride 625 mg/1 Details

    Colesevelam Hydrochloride 625 mg/1

    Colesevelam Hydrochloride is a ORAL TABLET, COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by American Health Packaging. The primary component is COLESEVELAM HYDROCHLORIDE.

    Product Information

    NDC 60687-0385
    Product ID 60687-385_0c53fe8c-e49d-ab3a-e063-6394a90a3424
    Associated GPIs 39100016100330
    GCN Sequence Number 046172
    GCN Sequence Number Description colesevelam HCl TABLET 625 MG ORAL
    HIC3 D7L
    HIC3 Description BILE SALT SEQUESTRANTS
    GCN 16300
    HICL Sequence Number 021452
    HICL Sequence Number Description COLESEVELAM HCL
    Brand/Generic Generic
    Proprietary Name Colesevelam Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Colesevelam Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, COATED
    Route ORAL
    Active Ingredient Strength 625
    Active Ingredient Units mg/1
    Substance Name COLESEVELAM HYDROCHLORIDE
    Labeler Name American Health Packaging
    Pharmaceutical Class Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA091600
    Listing Certified Through 2024-12-31

    Package

    NDC 60687-0385-25 (60687038525)

    NDC Package Code 60687-385-25
    Billing NDC 60687038525
    Package 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-385-25) / 1 TABLET, COATED in 1 BLISTER PACK (60687-385-95)
    Marketing Start Date 2018-08-09
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.25227
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description COLESEVELAM 625 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis